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ABSTRACT
Objective Concerns have been raised that the COVID-19 
pandemic has shifted research productivity to the 
disadvantage of women in academia, particularly in 
early career stages. In this study, we aimed to assess 
the pandemic’s effect on women’s COVID-19- related 
publishing over the first year of the pandemic.
Methods and results We compared the gender 
distribution of first authorships for 42 898 publications 
on COVID-19 from 1 February 2020 to 31 January 2021 
to 483 232 publications appearing in the same journals 
during the same period the year prior. We found that 
the gender gap—the percentage of articles on which 
men versus women were first authors—widened by 
14 percentage points during the COVID-19 pandemic, 
despite many pertinent research fields showing near equal 
proportions of men and women first authors publishing 
in the same fields before the pandemic. Longitudinal 
analyses revealed that the significant initial expansions 
of the gender gap began to trend backwards to expected 
values over time in many fields. As women may have been 
differentially affected depending on their geography, we 
also assessed the gender distribution of first authorships 
grouped by countries and geographical areas. While we 
observed a significant reduction of the shares of women 
first authors in almost all countries, longitudinal analyses 
confirmed a resolving trend over time.
Conclusion The reduction in women’s COVID-19- related 
research output appears particularly concerning as many 
disciplines informing the response to the pandemic had 
near equal gender shares of first authorship in the year 
prior to the pandemic. The acute productivity drain with the 
onset of the pandemic magnifies deep- rooted obstacles on 
the way to gender equity in scientific contribution.
INTRODUCTION
Women are integral to productive and inno-
vative science communities.1 2 Nonetheless, 
women remain under- represented in pres-
tigious author positions on publications 
in the life sciences and medicine,3 are less 
likely to be promoted to higher academic 
ranks and are paid less, despite the continu-
ously growing number of women academics.4 
Projections indicate that this gap will persist if 
targeted interventions are not implemented.5
It is in this setting that concerns have been 
raised that research and expert reporting 
on the COVID-19 pandemic has dispropor-
tionately involved men as scientific authors. 
For example, women submitted fewer manu-
scripts overall, were less available for peer 
review6–8 and attended fewer funding panel 
meetings.7 Also, women first authorship was 
significantly reduced on preprints and publi-
cations about COVID-19 in the USA9 10 and 
globally.11
It has been suggested that this might, at 
least in part, be due to an exacerbation of 
pre- existing work–family conflicts, espe-
cially for early- career mothers in academia.12 
With lockdown measures to prevent uncon-
trolled spread of the coronavirus came not 
only remote working, but also closures of 
childcare services like daycares and schools 
transferring teaching responsibilities often 
to mothers, without the possibility to involve 
family members in childcare that belong to 
the ageing population who are particularly 
Strengths and limitations of this study
 ► The COVID-19 pandemic is an exogenous source of 
variation that allows the examination of differential 
effects of the pandemic on women’s and men’s pub-
lishing activity.
 ► We used a retrospective cohort design, comparing 
author gender for COVID-19 articles with articles in 
similar fields published during the year prior to the 
pandemic.
 ► Data on affiliations, publishing journals and dates 
enable analyses of gender differences in publication 
rates by geography, scientific discipline and over 
time.
 ► This large- scale archival study did not allow dis-
entangling the mechanisms that underpin gender 
differences in publishing rates associated with the 
pandemic.
 ► The methodology relied on a probabilistic algorithm 
to assign gender to thousands of authors, bearing a 
residual risk of gender misclassification.
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vulnerable to severe illness from the coronavirus.12–16 
Evidence from Germany showed, for example, that 
women not only took over the physical load of increased 
childcare and household responsibilities, but also the 
mental load associated with taking care of the family 
during a pandemic.17 Even prior to the pandemic, 
research has shown that childrearing and household 
work were tasks largely taken care of by women, thereby 
impacting women’s academic careers more than men’s. 
For example, parental leaves taken by men often result in 
increased productivity, while no such phenomenon can 
be observed for women.18
The proliferation of COVID-19- related publications 
provides a unique window into these gendered dynamics 
for two reasons. First, COVID-19 publications have been 
produced rapidly under unusual conditions that likely 
disfavour women scientists relative to usual conditions 
that can serve as a control. Second, COVID-19 publica-
tions are mainly, though not exclusively, produced in the 
life sciences and medicine where long- standing author-
ship norms reserve the first author position to early career 
investigators leading the project, which allows estimating 
the repercussions for this group in particular. Therefore, 
we assessed the pandemic’s effect on women’s COVID-
19- related scientific publishing over the first year of the 
pandemic by analyses of first authorships in a longitudinal 
approach. We further performed analyses to quantify 
the effect per scientific specialty and country affiliation, 
as women may have been differentially affected across 
specialties and geographical areas.
METHODS
Study design and data
We use a retrospective cohort design, comparing the 
gender composition on the author byline of 42 898 
PubMed indexed life science articles that included the 
term ‘COVID’ in the title and/or abstract, and that were 
published between February 2020 and January 2021 to a 
set of 483 232 control articles published in the same jour-
nals a year earlier (see online supplemental material 1 for 
details on data and methods). The onset of the COVID-19 
pandemic in early 2020 (and ensuing countermeasures 
like lockdowns, remote work and so on) serves as a source 
of exogenous variation that affects authors of COVID-19 
articles but not authors who published research in the 
same journals prior to the COVID-19 outbreak, that is, 
our control group. To assess possible effect stratification 
across research areas, we allocated 3426 represented 
journals to scientific disciplines based on the disciplines 
provided in the Clarivate Journal Citation Report using 
unique International Standard Serial Numbers as a cross-
walk. We restricted this analysis to disciplines with at least 
50 publications per reported time period to provide more 
precise estimates. We obtained detailed affiliation records 
to determine the geographical locale of first authors for 
country- specific analyses. We restricted this analysis to 
countries with at least 50 publications, and continents 
with at least 10 publications per reported time point, to 
increase precision of estimates (see online supplemental 
figure 1 for details on the sample construction).
We further made use of a long- standing authorship 
norm in the life sciences, according to which the first 
author is usually the junior author who executed the 
research, while the last author is generally the senior 
author who funded and may have conceived of the 
research. To designate the probable gender of thousands 
of these authors in our dataset, we use the  genderize. io 
database that draws on a number of official sources, like 
Social Security Administration records and social media 
profiles, to assign a probability that a given forename 
is more likely held by men or women. For our analysis, 
we only included cases where the algorithm assigned a 
90% or greater probability to the individual being of a 
specific gender (see also online supplemental figures 
2–4). Overall, our applied inclusion criteria did not intro-
duce tangible selection bias in terms of fields or countries 
represented (see online supplemental tables 1 and 2).
Outcome measures
We calculated the gender gap in academic authorships as 
the absolute percentage point difference between men 
and women authors. For example, if men and women 
accounted for 55% and 45% of first author positions, 
respectively, the absolute gender difference would be 
10 percentage points. We also offered parametric anal-
yses in the supplement, analysing the effect of authoring 
during the pandemic versus not (a binary independent 
variable) on the likelihood that the first author was a 
woman versus a man (our outcome) (online supple-
mental tables 3–5).
Sensitivity analyses
We conducted additional sensitivity analyses (online 
supplemental tables 6 and 7), including varying the confi-
dence with which gender could be inferred, excluding 
articles with group authorships, rerunning our analyses 
for the full set of articles (ie, without applying sampling 
restrictions) and comparing sampled with non- sampled 
observations.
Patient and public involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved 
in developing plans for design or implementation of the 
study. No patients were asked to advise on the interpre-
tation or write up of the results. There are no plans to 
disseminate the results of the research to study partici-
pants or the relevant patient community.
RESULTS
One-year gender differences in first and last authorships 
related to COVID-19 publications
On average, men accounted for 54.9% and women for 
45.1% of first authorships in 483 232 articles, published 
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before the pandemic (between February 2019 and January 
2020), for an absolute gender gap of 9.8 percentage 
points. In contrast, men and women accounted for 62.3% 
and 37.7% of first authorships on COVID- related publi-
cations, for an absolute gender gap of 24.6 percentage 
points. The gender gap therefore widened by approx-
imately 14.8 percentage points in disciplines related to 
the COVID-19 pandemic (figure 1). Smaller changes 
were observed in last authorships. For example, while the 
gender gap in last authorships before the pandemic was 
expectedly much larger (approximately 36 percentage 
points), the effect of the pandemic on last author 
publishing by women was less pronounced (although 
statistically significant given the large sample size). On 
average, women accounted for 31.9% of last authorships 
in articles published before the pandemic, compared with 
30.5% of last authorships for COVID-19- related publica-
tions, representing a widening of the last author gender 
gap by approximately 2.8 percentage points (figure 1). 
In line with previous data, our results therefore indicate 
that junior women investigators were disproportionally 
affected by the pandemic.9–11 13 15 As women may have 
been differently affected depending on their field of 
study or depending on geography, we further sought to 
investigate gender differences particularly in first author-
ships according to field of study and country.
Longitudinal analysis of gender differences in first 
authorships on COVID-19 publications, by scientific discipline
As the first author gender gap in publications gener-
ally varies across fields,19 we calculated the first author 
gender gap by discipline. We allocated the journals that 
published on COVID-19 to scientific fields based on the 
disciplines represented in the Clarivate Journal Cita-
tion Report.20 As depicted in the first column of the 
heatmap in figure 2, disciplines producing most COVID-
19- relevant publications had shares of first authorship 
pre- COVID-19 by women of 45% (ie, an average gender 
gap of approximately 10 percentage points across all 
disciplines). During the pandemic, however, publications 
related to COVID-19 had an average 1- year gender gap 
of approximately 24 percentage points (ie, the share of 
first authorships from women for publications related 
to COVID-19 was 38%), a deviation of 14 percentage 
points (figure 2). This effect was most prominent in the 
first months of COVID-19 publishing, from February to 
May of 2020, when the gender gap rose to 36 percentage 
points (corresponding to a share of women first author-
ships of 32%). In the following months from June to 
September 2020, the share of women first authors slowly 
increased again to an average of 37%, and to 41% from 
October 2020 to January 2021, reducing the gender gap 
to 26 and 18 percentage points, respectively. However, 
this still represented a significant deviation from the pre- 
pandemic gender gap of 8 percentage points.
Interestingly, many of the disciplines that produced 
most COVID-19 publications had equal or near- equal 
gender shares in the year before the pandemic. For 
example, in the fields of virology, immunology, infec-
tious diseases and general/internal medicine, the shares 
of women first authors prior to COVID-19 were 50%, 
52%, 48% and 44%, respectively. The share of women 
first authors in other relevant fields like public, environ-
mental and occupational health was even higher (59%). 
In many relevant fields, the gender rift in first author-
ships for COVID-19- related publications widened signifi-
cantly above the pre- COVID-19 average. For example, 
while women were more likely to be first authors on 
publications within public, environmental and occupa-
tional health (difference of 18 percentage points) before 
the pandemic, the gap changed by 30 percentage points 
so that women were now less likely to publish research 
within this field as first authors of COVID-19- related 
publications (gender gap of 12 percentage points). In 
biochemistry and molecular biology, the gender gap in 
first authorships increased by 34 percentage points, from 
2 percentage points pre- COVID-19 to 36 percentage points 
for COVID-19 publications. In virology, the gender gap 
increased by 26 percentage points, from equal shares (no 
gap) to 26 percentage points for COVID-19 publications. 
Other COVID-19- relevant fields were much less prone 
to changes in the first author gender gap, for example, 
surgery, and cardiac and cardiovascular systems, in which 
the gender gap prior to COVID-19 was 44 percentage 
points compared with 46 percentage points for COVID-
19- related studies, respectively (meaning women’s first 
authorship shares were as low as 28% and 27%, respec-
tively) (figure 2).
Longitudinal analyses of gender differences in first 
authorships on COVID-19 publications, by affiliated 
geographical area
Since the pandemic has affected countries differently, we 
further performed analyses based on the country affili-
ation of the first author. Women’s research productivity 
Figure 1 Overall gender differences in first and last 
authorships related to COVID-19 publications. Gender gap 
in first and last authorships for COVID-19 publications (red) 
compared with the gender gap for control publications 
appearing in the same journals a year earlier (blue).
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went down in almost all countries (figure 3A). For 
example, in the USA, which accounted for ~26% of all 
COVID-19 publications between February 2020 and 
January 2021, women’s first authorship share decreased 
from a share of 44% to a share of 41% (corresponding to 
a widening of the gender gap by 6 percentage points). In 
European countries that were hit earlier by the pandemic 
than the USA, women’s representation in authorships 
was also more affected. In Italy, for example, women’s 
share of first authorships decreased from 49% before 
the pandemic to 35% for COVID-19- related publications, 
an increase in the gender gap of 28 percentage points 
because of the pandemic, with the overall number of 
publications from Italy accounting for 10% of total publi-
cations on COVID-19. The increase in the first authorship 
gender gap was also substantive in Brazil (30 percentage 
points), and Mexico (35 percentage points), Australia 
(14 percentage points) and India (22 percentage points). 
Only very few countries showed no change in the first 
authorship gender gap, including China (no change), 
South Korea (decreased by 3 percentage points) or 
Taiwan (decreased by 2 percentage points).
We further performed a granular time- resolved (per 
2 months) analysis of women’s first authorship shares 
grouped by continents. Our data showed that the largest 
reduction in women’s first authorship shares happened 
early in last spring (April and May 2020). In Europe, for 
example, the gender gap increased by 18 percentage 
points, in North America by 8 percentage points, in Latin 
America by 28 percentage points, in Australia and Oceania 
by 15 percentage points, in Africa by 18 percentage points, 
and in Asia by 7 percentage points (figure 3B). Similar to 
our analysis of the difference in first authorship shares 
over time by field, we found that the gap began to close 
again over time and seemed to have reached baseline 
levels in North America and Oceania. In all the other 
geographical areas, the gender gap has yet to reach the 
levels expected from the year prior to the pandemic, 
with Africa and Latin America being farthest from the 
baseline (12 percentage points, respectively) (figure 3B), 
while COVID-19- related research output has been rela-
tively stable from April 2020 to January 2021 within each 
geographic region.
DISCUSSION
Our results provide evidence for the COVID-19 pandem-
ic’s effect on women’s publishing productivity across 
Figure 2 Time- resolved gender differences in first authorship shares on COVID-19 publications, by scientific discipline. 
Heatmap depicting the gender gap in first authorships for COVID-19 publications and control publications from the same 
disciplines appearing in the same journals during the same period in the year prior to the pandemic. Fields sorted in descending 
order by number of publications. Red indicates an over- representation of women first authors, white indicates gender parity, 
blue indicates an over- representation of men first authors (in percentage points).
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disciplines, worldwide and over time. In line with our 
hypothesis, we found that the relative increase in the 
gender gap was more pronounced for women in the 
first author position. In light of previous research and 
observations,13 15 18 21 we suspected that the overcontri-
bution of women to household and childrearing respon-
sibilities—that leaves less opportunity to participate in 
writing, submitting and publishing research related to 
COVID-19—led to reduced productivity of early- career 
women investigators. However, aside from time constraints 
that disproportionally changed for women in an earlier 
stage of their career, other reasons are possible for the 
significant difference of women’s productivity with regard 
to COVID-19. For example, since COVID-19 emerged as 
a high- profile, and very publishable subject, it is possible 
that it was easier for men, who are still more likely to be in 
leadership and well- funded positions in academia to pick 
up the topic quickly. Also, women were less likely to func-
tion as expert reviewers on articles related to COVID-19,6–8 
known to potentially exacerbate a pre- existing gender 
bias in the peer- review and publishing process.22–24 These 
might contribute to a vicious cycle that hindered access 
to COVID-19 publishing especially for women in the early 
stages of their career.11 The exact determination of under-
lying mechanisms, however, warrants future research that 
might also benefit from longer time- series data.
Figure 3 Difference in first authorship gender gap, by country/geographical area. (A) World map depicting the deviation in the 
gender gap in first authorships for COVID-19 publications when compared with the expected gender gap derived from control 
publications from the same countries appearing in the same journals a year earlier. Red indicates an over- representation of 
women first authors, white indicates gender parity, blue indicates an over- representation of men first authors (in percentage 
points). (B) Time- resolved deviation in the gender gap in first authorships for COVID-19 publications when compared with the 
expected gender gap derived from control publications from the same geographical area appearing in the same journals a year 
earlier (in percentage points).
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Interestingly, we found that decreased publishing 
activity was specifically significant in fields that had a 
relatively equal share between women and men as first 
authors prior to the pandemic. Those were also fields that 
had a high overall productivity among COVID-19 articles. 
This is a reason for concern insofar as the current scien-
tific/medical response to one of the most incisive global 
crises could be overly dominated by men and missing 
expert voices by women that would usually be a vital part 
of this research.
Applying longitudinal analyses, we found that the 
much- increased gender gap in relevant fields was partic-
ularly noticeable early on and continuously trended 
back towards the baseline since then. However, recovery 
remains slow, with potential reasons being the extent 
of the impact, the fact that many fields with an above 
average share of women first authors were affected, but 
also because some of the most affected fields require 
in- person work, for example, in wet labs (eg, biochem-
istry, molecular biology, microbiology).
Analysing the change in the gender gap globally, we 
similarly found that the shares of women first authors 
declined across almost all geographic areas early in the 
course of the pandemic in spring of 2020. Since then, 
the gender gap slowly began to close again towards the 
expected baseline and even reached baseline in North 
America and Oceania. Asia is the only continent where 
no significant reduction in women’s first authorships was 
noted. In China, there was no change in gender compo-
sition among COVID-19 publication when compared 
with control publications. In Taiwan and South Korea, 
a small increase in women first author shares was 
noted. Given that these countries together accounted 
for 4.2% of COVID-19 publications in our dataset, and 
that gender designation algorithms tend to offer lower 
probability gender designations for Asian forenames, we 
are reluctant to conclusively interpret these findings. 
Of note, we applied a uniform probability threshold of 
90% for designating an author’s gender as a conserva-
tive measure.
Even though our longitudinal analysis leads us to be 
cautiously optimistic that the impact of the pandemic 
on women’s COVID-19 research activity might have 
been temporary, we speculate that the absence of many 
expert women voices during the initial response to the 
pandemic impacted not only the individual researchers, 
but also society as a whole. While our study focused on 
COVID-19 publications, the dynamics reported here 
may be amplified in research beyond COVID-19. Effects 
of the pandemic on early- stage or ongoing projects are 
likely to show with a time- delay and potentially have long- 
lasting consequences jeopardising efforts toward equity 
in academia. For example, women at earlier career stages 
have not been able to allocate enough time to their 
research, manuscript and grant writing, were bound to 
remote working instead of in- person work, were poten-
tially less likely to be allocated to leading roles on projects 
given the circumstances and so on.
To avoid long- term impacts on the academic advance-
ment and scientific contributions, the disproportionate 
impact of the pandemic on early- career women investiga-
tors needs serious consideration and immediate actions. 
In a first step we would suggest for an open discourse about 
how the pandemic has highlighted systemic and struc-
tural barriers preventing gender equity in academia.25 
Naturally, pre- existing inequities must be evaluated, and a 
long- term strategy has to be established to support equity 
in science.26 But more acutely, COVID-19- related gender 
inequities need to be addressed with direct measures, 
monetary and non- monetary, on both the political (eg, 
federal funding agencies) and institutional level. For 
example, financial support for postdoctoral/graduate 
students could help to facilitate a research setback in a 
recently established laboratory. Modifications for grant 
deadlines, timelines, extensions for granted expenses, 
as well as additional (bridge) funding programmes, are 
likely warranted for early- career mentored/indepen-
dent investigators.27 Extension of tenure evaluation and 
promotion should be considered on the individual level 
accounting for constraints posed by COVID-19 for junior 
faculty (for both men and women). Resources for child-
care should be provided for parents, additional funds for 
expanded childcare arrangements could help to reallo-
cate time to regular professional duties. However, it is 
as necessary to normalise the increased stress of living 
through a pandemic that not only affects professional 
obligations and goals, but also other family members, and 
no penalty should be awarded for caregivers but measures 
mentioned above should rather allow for extra quality 
time.28
Our study had several limitations. One limitation is that 
part of our large- scale study design was based on field 
association by Clarivate Journal categories, which bears 
a potential risk of misclassification or inclusion of articles 
from journals that might not follow the norm of author 
ordering with regard to contribution that we assume for 
the life sciences and medicine. For example, one of the 
most affected fields in our data analysis is public, environ-
mental and occupational health, where such norms might 
not be generalisable. However, previous research about 
the topic in public health, for example, also applied said 
authorship order norms and given the high relevance of 
the field and results, we decided to present the data.29 
Next, we relied on authors’ first names to designate their 
likely gender, which bears the risk of gender misclassi-
fication, particularly across different geographies. We 
attempted to minimise this risk by applying a 90% proba-
bility requirement, however, a certain level of uncertainty 
remains.30 Also, by design of the gender designation algo-
rithms grouping into two categories, namely ‘men’ and 
‘women’, we cannot separate out an effect for scholars 
who are non- binary, transgender men and women. Along 
those lines, by virtue of the large- scale nature of our 
study, we acknowledge that we cannot draw conclusions 
for researchers on the individual level as well as confirm 
the assumed career stage. While our study focused on 
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gender disparities for COVID-19- related research, it is 
important to note that, beyond gender diversity,31 ethnic 
and cultural diversity benefit science on multiple levels.32 
With our analyses, however, we cannot comment on how 
the pandemic might have affected ethnic and cultural 
diversity with regard to COVID-19- related research or if 
populations under- represented in academic life sciences 
were similarly affected. Lastly, in this observational study, 
we cannot causally decipher the underlying mechanisms 
leading to women being under- represented on COVID-
19- related research, also precluding a definitive explana-
tion for the trend back to baseline over time and what the 
potentially successful measures were or could be.
In conclusion, we found that women first authors have 
been under- represented in COVID-19- related research, 
particularly at the beginning of the pandemic, despite 
having nearly equal first authorship shares as men in 
pertinent fields prior to the pandemic.
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